Wof b2 agonist bronchodilators is given by inhalation, and is suitable for both terminating asthma attacks as well as for twice daily prophylaxis:
**Question:** Which of the following statements describes the correct mode of administration and clinical applications of a beta-2 agonist bronchodilator?
A. Administered orally for long-term prophylaxis
B. Administered subcutaneously for immediate relief of an asthma attack
C. Administered intramuscularly for emergency use
D. Administered via inhaler for twice daily prophylaxis and immediate relief of an asthma attack
**Correct Answer:**
**Core Concept:** Beta-2 agonist bronchodilators are a class of medications that directly stimulate beta-2 receptors in the airway smooth muscle, leading to relaxation and bronchodilation. This results in improved airflow in asthma patients. They come in various forms, such as inhalers, nebulizers, and injectables.
**Why the Correct Answer is Right:** Beta-2 agonist bronchodilators are typically administered via inhalation because it ensures direct delivery to the airways, providing rapid and localized effect. Inhalers, specifically pressurized metered-dose inhalers (pMDIs), dry powder inhalers (DPIs), and soft mist inhalers (SMI) are common delivery methods.
Beta-2 agonists have two primary applications:
1. **Terminating asthma attacks:** These medications can rapidly relieve bronchoconstriction in acute asthma exacerbations, effectively "saving the day" (or in medical terminology, "rescue therapy").
2. **Twice daily prophylaxis:** Regular administration (twice daily) is essential for maintaining airway dilation and preventing asthma attacks (prophylaxis).
**Why Each Wrong Option is Incorrect:**
A. Administration via oral route is not suitable due to poor bioavailability and systemic absorption, resulting in inadequate bronchodilation.
B. Subcutaneous administration delivers the medication systemically, providing inadequate local effect on airways and unnecessary risks of hypotension and tachycardia.
C. Intramuscular administration is not preferred due to poor local delivery to the airways and potential for systemic side effects.
**Clinical Pearl:** A thorough understanding of the mode of administration and clinical applications of beta-2 agonists is vital for effective asthma management. Choose the appropriate route and timing of administration based on the patient's condition and treatment goals.